Atopic Dermatitis Polypharmacy and Out-Of-Pocket Healthcare Expenses.

ABSTRACT:

Background

Atopic dermatitis (AD) out-of-pocket (OOP) expenses are substantial and impact household finances. Prescription polypharmacy and its association with OOP expenses in AD is poorly understood.

Objective

To characterize prescription polypharmacy and its association with OOP healthcare expenses among individuals with AD.

Methods

An online survey was administered to National Eczema Association members (N=113,502). Inclusion criteria (US resident, age ≥18, self-reported or caregiver of individual with AD) was met by 77.3% (1,118/1,447) of respondents.

Results

Polypharmacy (≥5 prescription treatments for AD in the past year) was associated with increased AD severity, poorer control, increased flares, increased healthcare provider visits, and comorbid

SUBMITTER: Chovatiya R 

PROVIDER: S-EPMC10156428 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature